EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 263 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2020. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $587,231 | -10.9% | 172,715 | +92.5% | 0.00% | -33.3% |
Q2 2023 | $659,435 | +43.2% | 89,719 | +101.8% | 0.00% | +50.0% |
Q1 2023 | $460,647 | +21.2% | 44,464 | +409.1% | 0.00% | +100.0% |
Q4 2021 | $380,000 | -56.9% | 8,733 | -50.5% | 0.00% | -75.0% |
Q3 2021 | $882,000 | +52.9% | 17,625 | +92.3% | 0.00% | +33.3% |
Q2 2021 | $577,000 | -30.3% | 9,165 | +2.8% | 0.00% | -25.0% |
Q1 2021 | $828,000 | -36.8% | 8,915 | -39.0% | 0.00% | -33.3% |
Q4 2020 | $1,310,000 | -14.5% | 14,620 | -1.5% | 0.01% | -14.3% |
Q3 2020 | $1,533,000 | +34.6% | 14,839 | +3.1% | 0.01% | +40.0% |
Q2 2020 | $1,139,000 | +21.7% | 14,399 | -11.0% | 0.01% | -16.7% |
Q1 2020 | $936,000 | +7.2% | 16,184 | 0.0% | 0.01% | +50.0% |
Q4 2019 | $873,000 | -27.2% | 16,184 | -29.4% | 0.00% | -33.3% |
Q3 2019 | $1,199,000 | +7.3% | 22,929 | -0.9% | 0.01% | 0.0% |
Q2 2019 | $1,117,000 | -4.4% | 23,129 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $1,168,000 | -15.9% | 23,129 | -1.2% | 0.01% | -33.3% |
Q4 2018 | $1,388,000 | -23.7% | 23,419 | -15.3% | 0.01% | -10.0% |
Q3 2018 | $1,819,000 | +22.5% | 27,639 | -6.0% | 0.01% | +25.0% |
Q2 2018 | $1,485,000 | -16.2% | 29,411 | -12.7% | 0.01% | -20.0% |
Q1 2018 | $1,773,000 | -40.3% | 33,681 | -47.3% | 0.01% | -37.5% |
Q4 2017 | $2,971,000 | +181.9% | 63,936 | +145.3% | 0.02% | +166.7% |
Q3 2017 | $1,054,000 | +303.8% | 26,062 | +238.4% | 0.01% | +200.0% |
Q2 2017 | $261,000 | -14.4% | 7,702 | -26.7% | 0.00% | 0.0% |
Q1 2017 | $305,000 | +47.3% | 10,512 | +59.9% | 0.00% | 0.0% |
Q3 2016 | $207,000 | -71.3% | 6,573 | -66.9% | 0.00% | -66.7% |
Q1 2016 | $722,000 | -56.9% | 19,854 | -52.6% | 0.01% | -60.0% |
Q4 2015 | $1,676,000 | +35.8% | 41,890 | -3.3% | 0.02% | +25.0% |
Q3 2015 | $1,234,000 | +77.8% | 43,310 | +105.6% | 0.01% | +100.0% |
Q2 2015 | $694,000 | +96.0% | 21,070 | +13.5% | 0.01% | +50.0% |
Q3 2013 | $354,000 | +35.1% | 18,565 | +2.0% | 0.00% | 0.0% |
Q2 2013 | $262,000 | – | 18,195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |